Christopher Banfield
- Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization 9
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 15
- Dermatology top 1%
- Dermatology and Skin Diseases 13
- Rheumatology top 2%
- Urology top 2%
-
- Asthma and respiratory diseases 15
-
- Pharmacological Effects and Toxicity Studies 14
- Pharmaceutical studies and practices 9
-
- Epilepsy research and treatment 10
-
- Inflammatory Bowel Disease 9
- Co-authors
- Melton B. AffrimeMichael S. VincentSamir K. GuptaPaul GlueElena PeevaMalcolm RowlandJosephine LimKaren Page
- Journals
- British Journal of Clinical Pharmacology (10 papers)Journal of Allergy and Clinical Immunology (9 papers)Clinical Pharmacokinetics (9 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Christopher Banfield
86 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Immunology and Allergy 325
- Pharmacology 425
- Dermatology 404
- Rheumatology 481
- Urology 166
Countries citing papers authored by Christopher Banfield
This map shows the geographic impact of Christopher Banfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Banfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Banfield more than expected).
Fields of papers citing papers by Christopher Banfield
This network shows the impact of papers produced by Christopher Banfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Banfield. The network helps show where Christopher Banfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Banfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 5 | |
| 5 | 2021 | 74 | |
| 6 | 2020 | 42 | |
| 7 | 2017 | 71 | |
| 8 | 2016 | 25 | |
| 9 | 2012 | 2 | |
| 10 | 2007 | 21 | |
| 11 | 2007 | 9 | |
| 12 | 2006 | 40 | |
| 13 | 2002 | 24 | |
| 14 | 2002 | 46 | |
| 15 | No drug interaction between fluoxetine and desloratadine, a new nonsedating once-daily antihistamine | 2001 | 4 |
| 16 | 2001 | 57 | |
| 17 | 1997 | 18 | |
| 18 | 1997 | 44 | |
| 19 | 1996 | 3 | |
| 20 | 1990 | 24 |
About Christopher Banfield
Christopher Banfield is a scholar working on Dermatology, Pharmacology, Immunology and Allergy, Pediatrics, Perinatology and Child Health and Immunology, having authored 88 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Asthma and respiratory diseases (15 papers), Pharmacological Effects and Toxicity Studies (14 papers), Dermatology and Skin Diseases (13 papers), Epilepsy research and treatment (10 papers), Allergic Rhinitis and Sensitization (9 papers), Pharmaceutical studies and practices (9 papers) and Inflammatory Bowel Disease (9 papers). The work is most often cited by research in Immunology and Allergy (325 citations), Pharmacology (425 citations), Dermatology (404 citations), Rheumatology (481 citations) and Urology (166 citations). Christopher Banfield has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Melton B. Affrime, Michael S. Vincent, Samir K. Gupta, Paul Glue, Elena Peeva, Malcolm Rowland, Josephine Lim, Karen Page, Desmond Padhi and Mark Laughlin. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Allergy and Clinical Immunology, Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.